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When attempting to answer questions of interest, scientists often encounter hurdles
that may stem from limited access to existing adequate datasets as a consequence
of poor data sharing practices, constraining administrative practices. Further, when
attempting to integrate data, differences in existing datasets also impose challenges that
limit opportunities for data integration. As a result, the pace of scientific advancements is
suboptimal. Synthetic data and virtual cohorts generated using innovative computational
techniques represent an opportunity to overcome some of these limitations and
consequently, to advance scientific developments. In this paper, we demonstrate the
use of virtual cohorts techniques to generate a synthetic dataset that mirrors a deeply
phenotyped sample of preclinical dementia research participants.
Keywords: AI/ML, virtual cohort, synthetic data, dementia, cohorts
INTRODUCTION
In 2019, the World Health Organization reported that around 50 million people had dementia
and there are nearly 10 million new cases every year (Alzheimer’s disease facts and figures,
2020). Dementia, a disease that affects an ever increasing proportion of the world’s population,
has ubiquitous deleterious effects on individuals which range from important deterioration of
individuals and family members’ well-being, to huge economic costs and considerable demand
of public health services (Prince et al., 2014) making the case for advancing our understanding of
dementia a critical priority for society. Scientific progress often results from synergetic interactions
and joint efforts of academia, industry and lay members of society. Yet, in dementia, these efforts
and interactions have not yet succeeded in the development of an effective treatment or cure for
the disease.
Observational studies and clinical trials are important resources in research. Observational
studies are mostly used to better understand the epidemiology of the disease and randomized
clinical trials are the gold standard for testing efficacy of new drugs. In the context of dementia
research, features of these studies have been discussed in the literature, and researchers have
highlighted some challenges and methodological limitations of both types of studies (Ritchie et al.,
2015). For instance, amongst other important features, limitations of the studies include their
deficient design, the erroneous selection of individuals into the studies and focusing on erroneous
outcomes. In fact, it has been argued that some of these features may partially explain the lack of
success in the development of disease-modifying treatments for dementia (Anderson et al., 2017).
Importantly, both types of studies heavily depend on the participation of individuals who
generously donate their time, data and specimens for research. In recent years, positive
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developments in research practices have resulted in increased
engagement of research participants in most aspects and stages
of research studies. However, the burden on participants can
become substantial, and key barriers still exist that discourage
some individuals from becoming involved in dementia research
(Cardona-Morrell et al., 2017). For instance, concerns about data
confidentiality and individuals’ privacy are important worries
that prevent some individuals from engaging in research (Grill
and Karlawish, 2010). Furthermore, in some contexts such as low
and middle income countries, where the number of dementia
cases are expected to increase at a rate faster than in high
income countries research and recruitment of study participants
is even more challenging for various factors, including the lack of
economic resources and cultural barriers (Ferri and Jacob, 2017).
Consequently, the recruitment of individuals into dementia
studies can be a challenging task for researchers, and as a result,
studies may not have the optimal design to answer questions
of interest.
Various practices further limit access and use of existing
data sources by researchers interested in conducting research,
although recent initiatives are making efforts to change
practice. Limitations include, amongst others, limited data
documentation, possessiveness of data and even limitations for
data transferring and storage (Deetjen et al., 2015).
Virtual cohorts are digital non-identical, yet highly similar,
synthetic data records that preserve the statistical properties
of the original data, that pose new opportunities to advance
dementia research. For instance, they may be used for the
simulation of clinical trials with specific designs (Koval et al.,
2019), to augment the size of datasets to improve the power
to detect effects of interest, or of under-represented groups in
a study (for example, ethnic minorities). They may also be
used when access to person-level data is challenging, offering
additional opportunities to analyse data that preserves the data
features whilst not using the real data. Indeed, virtual cohorts
have been used in other research areas such as heart models
(Niederer et al., 2020), and molecular and clinical analysis of
cancer virtual cohorts (Guan et al., 2020).
Yet, virtual cohorts are not incorporated in mainstream
dementia research. The aim of this paper is to demonstrate
the use of a virtual cohort to answer a commonly posed
question in dementia research about factors associated with
amyloid positivity using data from the European Prevention of
Alzheimer’s Dementia Longitudinal Cohort Study [EPAD LCS,
Ritchie et al. (2016)].
MATERIALS AND METHODS
EPAD LCS
The European Prevention of Alzheimer’s Dementia (EPAD)
project was initiated in January 2015 and is funded by the
Innovative Medicines Initiative (Ritchie et al., 2020). The EPAD
LCS had as its primary objective to be a readiness cohort for
the EPAD Proof of Concept Trial and its secondary objective
was to use the data generated for disease modeling. Based on
this secondary objective, we selected this dataset to illustrate
our methodology.
Research participants were eligible for inclusion if they were
over the age of 50 and should not have a diagnosis of dementia.
They must have also been deemed suitable in principle for later
inclusion in a clinical trial and therefore should not had any
medical or psychiatric disorders which would normally exclude
people from such trials.
At baseline and subsequent assessments, research participants
completed the entire protocol of assessments, which included
the assessments of various domains including basic demography,
fluid biomarkers, genetics, lifestyle, clinical, and psychiatric
assessment, neuropsychiatric symptoms, function, cognition, and
neuroimaging. For full details about the study protocol, please see
Solomon et al. (2019).
Specifically, sociodemographic information included data on
participants’ age, sex, and education (years). The only biomarkers
data collected in the EPAD LCS study are CSF (cerebrospinal
fluid) ABeta_1_42, Tau and Phosphorylated Tau (p-tau and t-
tau). Using data from CSF ABeta_1_42, a threshold of 1,000
pg/ml was agreed upon to define amyloid positivity.
With regards to cognition, participants completed the
Repeated Battery for the Assessment of Neuropsychological
Status [RBANS, Sullivan et al. (2018)] and they were all tested
for ApoE status. Sampling preparation and storage details can
be found in the EPAD lab manual (available online at http://
www.ep-ad.org). Similarly, participants were asked about their
family history of dementia, and their height and weight were
also measured.
Analytical Methods
From the original EPAD analytical database, the EPAD cohort of
1,500 patient records (EPAD V1500) were extracted, including
age, sex, ethnicity, years of education, height, weight, family
history of dementia, as well as the p-tau, t-tau, ABeta_1_42, and
RBANS. We performed pre-processing as follows:
• ABeta_1_42 in some cases has strings such as “>1,700”
or “<200”; those have been transformed to 1,701 and
199, respectively
• We created a new binary variable “abeta < 1,000,” with a value
of 0 if the ABeta_1_42 has a value <1,000 and 1 otherwise
• We computed body mass index (BMI) from height and weight
using the standard formula BMI= weight (kg)/height2 (cm)
• We computed a binary indicator of family history of dementia
that took the value of 1 if either father or mother had had
a history of dementia and they were the biological father or
mother (respectively).
Using this cohort, we used Syntegra’s synthetic data engine
to create a synthetic dataset which has the same schema and
validated the statistical fidelity of the synthetic data with the
real data.
For validation we applied a comprehensive set of methods as
described next.
Univariate Marginal Distributions
We compared univariate (marginal) distributions of the variables
between real and synthetic, and used the KS-statistics1 as
1Note that the Chi-Squared metric is also a good metric in this case.
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TABLE 1 | Descriptive statistics of the EPAD V1500 sample used and the synthetic data generated.
Variable Real data Synthetic data




Mean (SD) Mean (SD)
Height 41 166.7 (9.3) 38 167.0 (8.5) 0.32
Weight 37 73.4 (14.5) 38 74.5 (14.0) 0.42
BMI 41 26.3 (4.5) 38 26.6 (4.5) 0.07
P-tau 236 19.0 (10.2) 320 19.6 (10.1) 0.11
T-tau 236 219.6 (93.1) 320 227.1 (95.5) 0.06
ABeta_1_42 235 1247.4 (420.8) 320 1279 (421.1) 0.94
Abeta_calc 1,130 2276.5 (633.0) 1130 2283.4 (634.7) 0.88
Rad_pct 106 5681.2 (1055.3) 51 5800.7 (1131.7) 0.11
Age 0 65.6 (7.2) 0 65.5 (7.4) 0.78
Edu_years 8 14.5 (3.7) 1 14.3 (3.8) 0.14
Rbans_total 62 103.4 (13.7) 38 104.5 (13.0) 0.21
n (%) n (%)
Sex Female 0 852 (56.9%) 0 969 (64.7%) 0.06
Male 646 (43.1%) 529 (35.3%) 0.06
Ethnicity Asian 359 2 (0.2%) 322 1 (0.1%) 0.56
Black 2 (0.2%) 2 (0.2%) 0.99
Caucasian/White 1,128 (99%) 1,165 (99.1%) 0.43
Other 1 (0.1%) 2 (0.2%) 0.90
Hispanic 1 (0.1%) 3 (0.3%) 0.31
Latin American 1 (0.1%) 2 (0.2%) 0.56
Mauricienne 1 (0.1%) 0 (0%) 0.31
Moroccan 1 (0.1%) 1 (0.1%) 0.90
South East Asian 1 (0.1%) 0 (0%) 0.31
Family history No 0 575 (38.4%) 0 635 (42.4%) 0.08
Yes 923 (61.6%) 863 (57.6%) 0.15
ABeta_1_42 < 1,000 No 235 855 (67.7%) 320 830 (70.5%) 0.56
Yes 408 (32.3%) 348 (29.5%) 0.14
ApoE e2/e2 178 3 (0.2%) 123 5 (0.4%) 0.34
e2/e3 110 (8.3%) 106 (7.7%) 0.56
e2/e4 43 (3.3%) 58 (4.2%) 0.21
e3/e3 709 (53.7%) 620 (45.1%) 0.05
e3/e4 404 (30.6%) 526 (38.3%) 0.05
e4/e4 51 (3.9%) 60 (4.4%) 0.51
a goodness-of-fit metric for numeric variables and the KL-
divergence2 as a goodness-of-fit metric for categorical variables.
These two statistics are of statistical fidelity between the real
and synthetic variables. When the real distribution matches the
synthetic distribution, we expect
• The KS-statistics p-value to be high (>0.05), and the closer to
1.0 the better; this is a bit non-intuitive at first and is because
in this case our null hypothesis is that the two distributions are
2https://en.wikipedia.org/wiki/Kullback%E2%80%93Leibler_divergence
the same, so a low p-value represents a high likelihood of the
non-null hypothesis
• The KL-divergence to be low (as close to zero as possible).
Intuitively, KL-divergence reflects the information loss when
the distribution of the variable in synthetic data is used
to approximate the distribution in the real data, which
doesn’t lend itself to an easy interpretation in terms of
a clear threshold of “strong fidelity” vs. “weak fidelity”
in the same way KS-Statistics does; nevertheless, one
can compare the KL-divergence of a given variable over
multiple synthetic datasets and lower values mean better
statistical fidelity.
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Pairwise Variable Correlation
Wemeasured pairwise correlation between each pair of variables
in our dataset, using the Pearson correlation coefficient, and
compared the resulting heatmap of correlations between real
and synthetic. Furthermore, we computed the L1-norm of the
difference in correlation between real and synthetic cohorts,











Naturally, a low value of PCD-L1 indicates small average
difference in the correlation values between real and synthetic,
and thus high statistical fidelity of the synthetic data with the real.
Predictive Model Performance
To measure how well predictive models perform if trained on
the virtual cohort, we trained a predictive model for amyloid-
positivity (ABeta_1_42< 1,000) using some of the other variables
(excluding other outcome variables) as predictors; we trained two
models - one using the real data to train the predictive model, and
another using the virtual cohort.
In both cases we used:
(1) Gradient Boosted Trees (using the LightGBM3 python
library), a commonly used modeling technique.
(2) Logistic regression.
We measured the predictive performance of both models using
the area under the ROC-curve (AUC-ROC) and compared the
models. For high statistical fidelity between the real and virtual
cohort, we expect the AUC of the predictive model built with the
synthetic data to be similar to that built with the real.
For the GBM models, we further look at the feature
importance metric, using SHAP (SHapley Additive exPlanations)
values4, for our gradient boosted trees model, where we expect to
see relative stability in feature ranking (and understanding that
this can change due to the inherent randomness of the GBM
algorithm). We use normalized Discounted Cumulative Gain5
(nDCG) to measure the difference in ranking.
Discriminator AUC
Inspired by generative adversarial networks, another effective
metric for multivariate fidelity is the “discriminator AUC.”
Concretely, we built a classificationmodel trained to discriminate
between patient records in the real data vs. the synthetic
data; using ROC-AUC as a measure of performance for this
discriminator model, a virtual cohort with high statistical fidelity
to the real cohort will result in a ROC-AUC value for this
discriminator model that is close to 0.5 (representing random
decision classifier), whereas low fidelity is reflected with ROC-
AUC values closer to 1.
UMAP-Based Dimensionality Reduction
UMAP6 is a modern dimensionality reduction technique that is
often used to understand clustering of points in high dimensional
space. It is informative to inspect the 2D projection of real and





two dimensions via UMAP, and visualize the various clusters
formed; specifically, we expect high fidelity synthetic data to
demonstrate broad coverage, such that in every cluster for the
real data, there is enough number of synthetic data points.
Distance-To-Closest-Row (DCR)
We demonstrate privacy of the synthetic data by measuring
the distance of each synthetic record to its closest record in
the real dataset. Concretely we visualize two distributions: (1)
the distance between each synthetic record and its closest real
record and (2) the distance between each real record and its
closest real record (excluding itself of course). For this purpose,
we implement a distance function between two records. Given
two records X = (X0, X1, . . . , Xp) and Y = (Y0, Y1, . . . , Yp), we
bin event numeric variables into 25 bins (thus, numeric values
turn into a categorical value), and compute the distance between










0 if Xi = Yi
1 otherwise
When DCR values are close to zero, that means synthetic records
are similar to the original records resulting in reduced privacy
protection. Importantly, the original data may already include
significant similarity between records or even explicit duplicates,
and so we visualize DCR of real-vs.-real and real-vs.-synthetic to
fully understand any reduction in risk.
RESULTS
Descriptive measures of the set of key variables used in the
analyses from the EPAD V1500 sample and the synthetic dataset
are shown in Table 1.
We evaluated the synthetic data generated applying the
Syntegra methodology to the EPAD V1500 dataset according
to the instruments described before. Unless stated otherwise, in
all the following experiments, the number of synthetic samples
generated is identical to the number of samples in the real dataset,
although synthetic data generation allows for generation of any
desired number of synthetic records. In all visualizations (if
appropriate) we use the color blue to represent real data and the
color green to represent synthetic data.
Univariate Marginal Distributions
We generated univariate distributions for selected variables
in the dataset. Figure 1 displays the univariate distributions
for these selected variables in the dataset; a summary of the
KS-statistic (for categorical variables) and KL-divergence (for
numeric variables) are shown in Tables 1, 2.
Pairwise Variable Correlation
For the sake of brevity, we present pairwise correlations
in graphical form. Figure 2 displays a heatmap of pairwise
correlations for real data compared to the synthetic data.
The calculated PCD-L1 is 0.0367, a value that indicates small
average difference in the correlation values between real and
synthetic, and thus high statistical fidelity.
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FIGURE 1 | Univariate distributions of Age, BMI, t-tau, ApoE gene, Sex, and family history.




ABeta_1_42 0.4175 Abeta_1_42 < 1,000 0.0344
Abeta_calc 0.9999 Apoe4_result 0.0345
Age 0.9999 Ethnicity 0.0031
Body mass index 0.9999 Family historyof dementia 0.0005






Rbans score _total 0.9870
Predictive Model Performance
We trained a gradient boosted trees classifier to
predict ABeta_1_42 < 1,000, which is an indicator for
dementia. We tuned the model parameters to achieve
the best model performance using 50 iterations of hyper
parameter tuning. The resulting Receiver Operating
Curve (ROC) and area under the ROC (or C-statistic) are
in Figure 3.
The ROC curves are demonstrating similar characteristics;
we ran this analysis multiple times with varying random
initialization each time, resulting in
• For GBM: AUC for real data is 0.6385 ± 0.0109 and for
synthetic is 0.6745± 0.0096
• For Logistic regression: AUC for real data is 0.7232 ± 0.0034
and for synthetic is 0.7032± 0.0028.
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FIGURE 2 | Pairwise distributions.
FIGURE 3 | Receiver operating curves for real vs. synthetic (single run).
Feature Importance Ranking
For the Gradient boosted trees model, we compared the feature
importance ranking, using SHAP values, of our real model vs. the
feature ranking of the synthetic model, as shown in Figure 4.
The nDCG metric comparing these two feature rankings
is 0.9244.
Discriminator AUC
The calculated discriminator AUC, as described
in the “Methods” section above resulted in 0.5320
± 0.0339 which is close to the desired level of
0.5, reflecting good statistical match between real
and synthetic.
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FIGURE 4 | Feature importance using SHAP values compared.
FIGURE 5 | UMAP visualization of real (left) vs. synthetic (right) data points in 2D.
UMAP Dimensionality Reduction
Figure 5 displays the UMAP real-vs.-synthetic 2D scatterplot,
demonstrating good coverage of real vs. synthetic in all clusters.
In calculating the UMAP visualization, we used the open
source UMAP python package umap-learn7, with n_neighbors=
7https://pypi.org/project/umap-learn/
50 and min_dist = 0.1. Importantly, umap is trained on the real
data and both real and synthetic data is transformed to the 2D
dimension using the same learned model.
Distance-To-Closest-Row (DCR)
Figure 6 also depicts the DCR distribution of the real vs.
synthetic data.
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FIGURE 6 | DCR – real on the left (blue), synthetic on the right (green).
The ratio between mean-dcr values for the real and synthetic
data provides a quantitative measure of privacy. For this dataset
the ratio was: 0.9995 which is excellent, although we do see a
slight shift to the left in the synthetic distribution as compared
to the real.
DISCUSSION
We demonstrated the use of synthetic data generated using
the Syntegra methodology to produce a virtual cohort of non-
identical digital records that preserve the statistical properties of
the EPAD V1500 dataset. We showed the fidelity of synthetic
data generated, reporting a series of commonly used indices that
consistently revealed high degree of similarity at the individual
level data between the original dataset and the virtual cohort at
the individual level data.
Our work, albeit being an application of modern
computational approaches without aiming to answer any
specific clinically relevant question, is a clear illustration of the
advantages that virtual cohorts via synthetic data generation
offer to the research community. Virtual cohorts represent quick
and cost-effective opportunities to advance research, overcoming
several of the existing hurdles that slow down or even impede
scientific developments. For instance, by using virtual cohorts
researchers would avoid lengthy and time-consuming data
transfers, which would become unnecessary and obsolete, whilst
having access to data that preserves the properties of the original
datasets of interest whilst also preserving confidentiality and
data privacy.
Notably, the generation of virtual cohorts by demand, that
is, the generation of tailored synthetic datasets generated for
answering specific questions, is another advantage of this
technique. However, its feasibility needs to be further explored
and may require appropriate documentation registering all steps
taken for later external data quality examinations.
The aim of our work was to illustrate, via a specific example,
how an advanced synthetic data generation technique could
produce a dataset that preserves all features of the true cohort.We
show the similarities between the real and the synthetic cohort
in a cross-sectional setting. Although we do not demonstrate
the use of virtual data in longitudinal designs, techniques exist
that permit similar work in these more complex designs, and the
recent release by Aridhia and EPAD of the EPAD V.IMI, that
contains longitudinal data for over 2,000 participants, can be used
for this purpose.
In the very near future, researchers developing and using
virtual cohorts in research areas such as dementia research will
need to engage with regulatory institutions and industry to
explore their systematic use and acceptance of results generated
using virtual cohorts. Most importantly, the community still
needs to engage with participants to better understand their
view regarding the use of their data for the implementation
of this approach. Clearly, efforts to continue collecting data
need to continue and be further supported as new datasets
will always be necessary to answer questions that emerge
as scientific knowledge advances. We are not advocating for
stopping data collections of new data. Instead, we advocate
for the exploration of new opportunities that virtual cohorts
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offer to maximize the utilization of existing datasets whilst
overcoming some of the hurdles that currently disrupts
science progression.
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